Lenalidomide and Valproic acid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lenalidomide (lenalidomide) and Valproic acid (valproic acid). Common drug interactions include cardiac arrest among females and leukopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Lenalidomide and Valproic acid. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Valproic acid?

Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 36,193 Valproic acid users. Check the latest studies of Valproic acid.



On Aug, 03, 2026

18 people who take Lenalidomide and Valproic acid together, and have interactions are studied.

Lenalidomide and Valproic acid drug interactions.

What are the common drug interactions of Lenalidomide and Valproic Acid, by gender? *:

female:

  1. Cardiac arrest
  2. Pulmonary sepsis (pus in lungs)

male:

  1. Leukopenia (less number of white blood cells in blood)
  2. Anaemia (lack of blood)
  3. Chest pain
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Coronary angioplasty
  8. Depression
  9. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  10. Dysgeusia (disorder of the sense of taste)

What are the common drug interactions of Lenalidomide and Valproic Acid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Alopecia (absence of hair from areas of the body)
  2. Anticonvulsant drug level increased
  3. Conjunctivitis (pink eye)
  4. Keratitis (eye's cornea, the front part of the eye, becomes inflamed)
  5. Radiation skin injury

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Immunosuppression
  2. Jc virus infection
  3. Paresis (a condition of muscular weakness)
  4. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
  5. Anaemia (lack of blood)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Arteriosclerosis (thickening and hardening of arteries)
  9. Arthralgia (joint pain)
  10. Back pain

60+:

  1. Leukopenia (less number of white blood cells in blood)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Tremor (trembling or shaking movements in one or more parts of your body)
  4. Anaemia (lack of blood)
  5. Bacterial infection
  6. Death
  7. Dysarthria (speech disorder)
  8. Gastrointestinal neoplasm (cancer tumour of digestive tract)
  9. Joint swelling
  10. Microangiopathic haemolytic anaemia (anaemia due to inability of bone marrow to compensate the premature destruction of red blood cells)

What are the existing conditions these people have? *

  1. Sleep Disorder: 8 people, 44.44%
  2. Multiple Myeloma (cancer of the plasma cells): 7 people, 38.89%
  3. Tumor: 3 people, 16.67%
  4. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 11.11%
  5. Bone Marrow Tumor Cell Infiltration: 2 people, 11.11%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 5.56%
  7. Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 1 person, 5.56%
  8. Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 5.56%
  9. Malignant Neoplasm Progression (cancer tumour came back): 1 person, 5.56%
  10. High Blood Cholesterol: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and Valproic acid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lenalidomide and Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Valproic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valproic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide and valproic acid (the active ingredients of Lenalidomide and Valproic acid, respectively), and Lenalidomide and Valproic acid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: